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a b s t r a c t
A case of a family suffering from arrhythmogenic cardiomyopathy affecting dominantly the
left ventricle of the heart was diagnosed in our hospital. A forty-six-year-old man was
admitted to the emergency room because of a collapse with both respiratory and circulatory
arrest during a sport activity. Fibrillation of the ventricles was initially registered upon
electrocardiography, and there had been several sudden deaths at a young age in the
patient's family. There was no signiﬁcant stenosis of his coronary arteries and because
of the electrocardiographic and echocardiographic  ﬁndings, cardiac magnetic resonance
was indicated. The cardiac magnetic resonance ﬁnding on the patient's heart probably
corresponds to a less frequent type of arrhythmogenic cardiomyopathy with dominant left
ventricular involvement. The patient's ﬁrst-degree relatives underwent comprehensive
examinations at our cardiology department, and a similar cardiac magnetic resonance
ﬁnding concerning the heart was made in the younger brother of the proband. Both brothers
had an implantable cardioverter-deﬁbrillator implanted and the whole family remains
subject to regular follow-ups at our department.
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.Introduction
Arrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD) is a hereditary disease caused by progressive replace-
ment of the right ventricle (RV) myocardium by ﬁbro-fatty tissue
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0010-8650/# 2014 The Czech Society of Cardiology. Published by Elseand slowly progressing ventricular dysfunction [1]. It is mostly
an autosomal dominant hereditary disease with variable
expressivity and penetrance [2]. This disease is not very
common, with an estimated prevalence of 1:5000. Patients
suffering from ARVD manifest with the ﬁrst symptoms
(palpitations, pre-syncope, syncope or sudden cardiac death)
within the second to ﬁfth decade of their life [3].Novotny), roman.panovsky@fnusa.cz  (R. Panovsky),
arkova), ilga.grochova@fnusa.cz (I. Grochova),
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Fig. 1 – (a and b) Cardiac magnetic resonance. Cine
sequences (TRUE FISP CINE) of 4-chamber view in diastole
(a) and systole (b) showing impaired systolic function and
regional akinesis of the apex and anterolateral free wall of
the left ventricle (arrows).
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A forty-six-year-old man was admitted to the hospital because
of a collapse with respiratory and circulatory arrest during a
sport activity. Cardiopulmonary resuscitation (CPR) was
immediately started and an ambulance arrived within
5 min. Ventricular ﬁbrillation was registered on the initial
electrocardiography (ECG). The CPR took 10 min altogether and
during this time the patient was deﬁbrillated three times and
then taken to the emergency room of our hospital.
The ECG upon admission registered sinus rhythm with
ST segment depressions and negative T waves in leads I, II,
aV3–V6 and Rsr' morphology of the QRS complex in leads I, II,
aVL, aVF, V5 and V6. Sinus rhythm without any malignant
arrhythmia persisted during the whole hospitalization. There
was signiﬁcant positivity of Troponin T (0.078 mg/l; range
0–0.014 mg/l). The echocardiography found akinesis of the apex
and adjacent part of the septum and apical part of the left
ventricular (LV) anterior wall with global ejection fraction (EF)
of 30%. The patient negated any typical chest pain; he felt only
a certain discomfort in the chest while moving or taking a deep
breath as a result of the resuscitation.
While taking down the family history, several sudden
deaths at a young age were mentioned – the patient's father
and brother had died of ventricular ﬁbrillation aged 43 and
33 respectively. Several female relatives from the father's side
died suddenly at a young age. The patient now has three living
relatives – a 35-year-old brother and two daughters aged
10 and 18, who feel subjectively healthy.
The patient was treated for arterial hypertension, hyperli-
poproteinemia and thrombophilia (homozygote for the gene
PAI – 1 encoding platelet activation inhibitor, heterozygote for
the gene P1A2 – GP IIIa encoding platelet surface adhesive
glycoprotein IIIa). He has undergone follow-ups at the
cardiology department since 2004, when the ﬁrst coronary
angiography was performed after a bicycle stress test with
frequent ventricular extrasystoles – there was no stenosis on
the coronary arteries, and EF was 72%. Then patient under-
went annual cardiology examinations with an echocardiogra-
phy registering the impairment of EF. In 2011 the bicycle stress
test was repeated with frequent ventricular extrasystoles
during resting and restitution, which disappeared during
exercise. A repeat coronary angiography was indicated, and
akinesis of the apex, hypokinesis of part of the anterior LV wall
with LVEF 37%; and left anterior descending artery (LAD)
stenosis of less than 40% were found.
During this hospitalization, following an ECG and echocar-
diographic ﬁnding after admission to emergency, acute
coronary angiography was indicated – 20% and 40% stenoses
of the LAD (speculation about spontaneous opening of the
arterial closure) and haemodynamically insigniﬁcant stenoses
on the circumﬂex artery and the right coronary artery with
LVEF 30% were described.
A cardiac magnetic resonance (CMR) was performed. Mild
dilatation of the left cardiac cavities, borderline dimensions of
the right ventricle (RV) and global EF 41% were reported.
Akinesis of the lateral LV wall and apex (Fig. 1) and minor
akinesis of part of the RV inferior wall (Fig. 2) were described on
native cine sequences. Subepicardial, locally transmural,lipomatosis of the LV lateral wall and apex was described
on T1-weighted sequences (Fig. 3). Late gadolinium enhance-
ment (LGE) was described in the same areas and in the akinetic
part of the RV inferior wall after gadolinium contrast agent
administration (Figs. 4 and 5).
A genetic examination and DNA analysis of the RYR2 gene
was performed, and sequence changes in exons 95, 98 and 102
were found. RYR2 gene mutations are sometimes associated
with ARVD and changes in these exons are registered in
mutation database [4]. However, these sequence changes are
so frequent that we cannot exclude the possibility that it
is just a polymorphism. Later new generation sequencing
(NGS) of 46 genes associated with cardiomyopathies was
performed, and two potentially pathogenic mutations were
found. The ﬁrst one was in the DSG2 gene encoding
desmosomal protein desmoglein, and the other one was in
the DES gene encoding cytoskeletal protein desmin, which is
linked to desmosomes.
After evaluation of all the examinations undertaken, a
secondary preventive implantable cardioverter-deﬁbrillator
(ICD) implantation was indicated and chronic medication was
modiﬁed (a higher dose of beta blocker, and clopidogrel was
added due to the thrombophilia). A comprehensive cardiology
Fig. 2 – (a and b) Cardiac magnetic resonance. Cine
sequences (TRUE FISP CINE) of short-axis view in diastole
(a) and systole (b) depicting akinesis of part of the inferior
wall of the right ventricle (arrow).
Fig. 3 – Cardiac magnetic resonance. Regions of
hyperintensity on T1-weighted sequences depicting
lipomatous infiltration of the right ventricle wall and apical
segment of the left ventricle lateral wall (arrows).
Fig. 4 – Cardiac magnetic resonance. Long-axis, 2-chamber
view approximately 10 min after gadolinium contrast
agent administration showing intramural, in places
transmural, late gadolinium enhancement in the apical
segment of the left ventricle (arrows).
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recommended. The older patient's daughter underwent a
CMR examination with normal ﬁndings.
Later, the patient's 35-year-old brother was examined. He
was an active athlete (marathon running), and so far had been
followed-up only for hyperlipoproteinemia. While taking
down his detailed history he mentioned recurrent presyn-
copes and a syncope during sport activity. Echocardiography
reported normal systolic and diastolic function of non-dilated
ventricles with EF 63%. Resting ECG showed sinus rhythm
without any pathological changes, but 24 h ECG monitoring
showed frequent isolated monomorphic ventricular extra-
systoles. He then underwent coronary angiography with no
stenosis on the coronary arteries. Later a CMR was carried out
with very similar ﬁndings concerning the heart as the older
brother's: non-dilated ventricles, slight elongation of the LV in
the long axis with diminutive pseudo-aneurysm in the apex
(Fig. 6) and minor akinesis of the inferior RV wall (Fig. 7). Areas
of hyperintensity on the borderline of the middle and apical
segment of the inferolateral LV wall were seen on T1-weighted
sequences, which mark ﬁbro-fatty inﬁltration of the myocar-
dium (Fig. 8). After gadolinium contrast agent administration,
extensive intramural LGE in the whole apical segment of the
LV and in the part of the inferior RV wall corresponding to the
focus of akinesis were reported (Fig. 9). Because of this CMR
ﬁnding and the family history, an ICD implantation in primary
preventive indication was performed and reduction of sport
activities was recommended.
Fig. 5 – Cardiac magnetic resonance. Short-axis view
approximately 10 min after gadolinium contrast agent
administration. Late gadolinium enhancement in the
akinetic part of the inferior wall of the right ventricle and
lateral wall of the left ventricle (arrows).
Fig. 6 – (a and b) Cardiac magnetic resonance. Cine
sequences (TRUE FISP CINE) of 4-chamber view in diastole
(a) and systole (b) showing slightly aneurysmatic formation
of the apex (arrow) of the elongated left ventricle with
preserved systolic function and normal kinetics.
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Coronary artery disease, storage or inﬁltrative disease (amy-
loidosis), cardiac sarcoidosis and ARVD affecting dominantly
the LV were considered in the differential diagnosis. Ischaemic
aetiology was less probable because of the absence of
signiﬁcant coronary artery stenosis in both brothers. Patients
suffering from cardiac amyloidosis usually demonstrate
distinctive global subendocardial LGE [5], so that cardiac
amyloidosis was rather unlikely. Cardiac sarcoidosis can
manifest with similar symptoms as ARVD. Typical symptoms
of cardiac sarcoidosis are conduction system abnormalities,
mediastinal lymphadenopathy, extracardial manifestation
and scarring in the interventricular septum seen on CMR [6].
None of these symptoms was present in either brothers. After
exclusion of these three possible diagnoses we started to focus
on ARVD.
The basic ARVD diagnostic methods are non-invasive
methods such as ECG, echocardiography or CMR. In ARVD
patients, conduction abnormalities can be found on ECG
(epsilon waves, negative T waves, ventricular arrhythmia).
Another typical ECG changes can be registered on high
sensitivity ECG – especially late potentials. On 24 h ECG
monitoring frequent ventricular extrasystoles or paroxysms of
ventricular tachycardia might be registered. Electrophysiolog-
ical study and endomyocardial biopsy are the most suitable
invasive diagnostic methods. However, endomyocardial biop-
sy has some limitations: the biopsy is usually taken from the
septum, but ARVD often involves the RV free wall; taking an
endomyocardial biopsy from a ﬁbrotized RV free wall is not
common because of the very high risk of perforation and
pericardial tamponade. No endomyocardial biopsy wasperformed in our patients, because the main affection was
in the LV and in the basal free wall of the RV.
The family history of ARVD or sudden death is also
considered. A scoring system known as ‘‘Revised task force
criteria’’ was developed to facilitate ARVD diagnostics [7]
(Table 1). These criteria were designed for the more frequent
type of ARVD affecting the right ventricle and are based on
medical history, morphological, functional and conduction
abnormalities. Task force criteria are divided into major and
minor according to the degree of pathological changes. The
diagnosis of ARVD is deﬁnite, when the patient meets 2 major
or 1 major and 2 minor or 4 minor criteria from different
categories. If the patient meets 1 major and 1 minor or 3 minor
criteria from different categories, the diagnosis of ARVD is
borderline. If the patient meets 1 major or 2 minor criteria from
different categories, the diagnosis of ARVD is possible. When
these criteria are slightly adapted to the left ventricular
involvement, our ﬁrst patient met 4 major criteria (negative T
Fig. 7 – (a and b) Cardiac magnetic resonance. Cine
sequences (TRUE FISP CINE) of short-axis view in diastole
(a) and systole (b) showing hypokinesis of part of the
inferior wall of the right ventricle (arrow).
Fig. 8 – (a and b) Cardiac magnetic resonance. Regions of
hyperintensity on T1-weighted sequences depicting
lipomatous infiltration of the left ventricle lateral free wall
(a, b) and the right ventricle inferior wall close to the
septum (b) (arrows).
Fig. 9 – Cardiac magnetic resonance. Long-axis, 4-chamber
view approximately 10 min after gadolinium contrast
agent administration showing intramural late gadolinium
enhancement in the apex and apical segment of the lateral
wall of the left ventricle (arrows).
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His brother met 1 major (family history) and 2 minor criteria
(CMR ﬁnding and frequent ventricular extrasystoles).
Genetic testing of patients suffering from ARVD has made a
certain progress in the past few years. Particular attention is
paid to the genes encoding desmosomal proteins (structures
providing intercellular connection and communication). So
far, a relationship with ARVD was proved by these genes: JUP
encoding plakoglobin [8], DSP encoding desmoplakin [9], PKP2
encoding plakophilin-2 [10], DSG2 encoding desmoglein-2 [11]
and DSC2 encoding desmocollin-2 [12]. Genes encoding non-
desmosomal proteins are also subject to research [13].
The most important tasks in ARVD therapy are prevention
of sudden cardiac death from fatal arrhythmia, prevention or
deceleration of the disease progression, and psychological
preparation of the patient for the life with a chronic disease
[14]. ICD implantation as a prevention of sustained ventricular
tachycardia and sudden cardiac death should be considered.
Beta blockers and class III antiarrhythmics (sotalol, amiodar-
one) are used in chronic pharmacotherapy to decrease the
number of arrhythmias and ICD discharges. Another thera-
peutic option in ARVD patients with frequent ventricular
Table 1 – Revised task force criteria.
Depolarization/conduction abnormalities
Major Epsilon wave (V1, V2, or V3)
Minor Signal averaged ECG in the absence of QRSD >110 ms
fQRS duration >114 ms or
Duration of terminal QRS <40 mV ≥ 38 ms or
Root-mean-square voltage of terminal 40 ms ≤ 20 mV
Terminal activation delay ≥55 ms
Repolarization abnormalities (in patients >14 years of age)
Major Negative T-wave in V1, V2, and V3 (without complete RBBB)
Minor Negative T-wave in V1 and V2 or in V4, V5, or V6 (without complete RBBB)
Negative T-wave in V1, V2, V3, and V4 with complete RBBB
Ventricular arrhythmias
Major Non-sustained or sustained VT with LBBB pattern with superior axis
Minor Non-sustained or sustained VT with LBBB pattern with inferior or
unknown axis
>500 premature ventricular complexes/24 h
Imaging techniques
Major 2D echocardiography
Regional RV akinesia, dyskinesia, or aneurysm and
PLAX RVOT >32 mm (or PLAX RVOT >19 mm/m2} or
PSAX RVOT >36 mm (or PSAX RVOT >21 mm/m2) or
Fractional area change <33%
MRI
Regional RV akinesia, dyskinesia, or dyssynchronous RV contraction and
Ratio of RVEDV to BSA >110 ml/m2 (male) or >100 ml/m2 (female) or
RV ejection faction <40%
RV angiography
Regional RV akinesia, dyskinesia, or aneurysm
Minor 2D echocardiography
Regional RV akinesia or dyskinesia and
PLAX RVOT ≥29 to <32 mm (or PLAX RVOT ≥16 to <19 mm/m2) or
PLAX RVOT ≥32 to <36 mm (or PLAX RVOT ≥18 to <21 mm/m2) or
Fractional area change ≥33 to <40%
MRI
Regional RV akinesia, dyskinesia, or dyssynchronous RV contraction and
Ratio of RVEDV to BSA ≥100 to <110 ml/m2 (male) or ≥90 to >100 ml/m2
(female or)
RV ejection faction ≥40 to <45%
Histology (endomyocardial biopsy from RVFW with ﬁbrous replacement)
Major Residual myocytes <60% on morphometric analysis (or <50% estimated)
Minor Residual myocytes 60–75% on morphometric analysis (or 50–65% esti-
mated)
Family history
Major First degree relative with ARVC according to current task force criteria
First degree relative with pathologically conﬁrmed ARVC (surgery or
atopsy)
Pathogenic mutation categorized as associated or probably associated with
ARVC
Minor First degree relative with ARVC undetermined whether diagnosis meets
current task force criteria
First degree relative with sudden death <35 years of age suspected to be
related to ARVC
Second degree relative with ARVC according to current task force criteria
Adapted from Marcus et al. [7].
RBBB, right bundle branch block; VT, ventricular tachycardia; LBBB, left bundle branch block; PLAX, parasternal long-axis view, RVOT, right
ventricular outﬂow tract; PSAX, parasternal short-axis view; RVEDV, right ventricular end diastolic volume; BSA, body surface area; RV, right
ventricle, ARVC, arrhythmogenic right ventricular cardiomyopathy.
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is considered in a few patients with rapid heart failure
progression or non-controllable ventricular arrhythmia as a
last possible therapeutic alternative [15]. Restriction of sport
activities represents an important preventive measure [16,17].Despite the improvement in ARVD diagnostics and therapy,
it is necessary to follow-up these patients, and cardiology
follow-up including consideration of primary-preventive ICD
implantation in asymptomatic ﬁrst-degree relatives is recom-
mended.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 9 6 – e 4 0 2e402Conclusions
According to clinical symptoms, family history and CMR
ﬁnding, especially in the older brother, an atypical form of
ARVD with dominant LV affection constitutes the most
probable diagnosis. Considering the malignant arrhythmia
and history of syncope, both brothers had an ICD implanted
and they remain subject to follow-up at our department along
with their ﬁrst-degree relatives. DNA analysis in the ﬁrst-
degree relatives has been planned recently to search for
potentially pathogenic mutations in the family.
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